Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration

Neurotoxicity Research

Volumn 8, Issue 1-2, 2005, Pages 187-198

  Nosheny, Rachel L ^a   Mocchetti, Italo ^a   Bachis, Alessia ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; BDNF; Caspase 3; CXCR4; Gp120; HIV 1 envelope proteins; Neuroprotection, Trk

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLYCOPROTEIN GP 120; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROPROTECTIVE AGENT; PROTEIN TYROSINE KINASE A;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; REVIEW; TOXICITY AND INTOXICATION;

AIDS DEMENTIA COMPLEX; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRUG DELIVERY SYSTEMS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA;

EID: 33644834963     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033829     Document Type: Review

References (105)

1. Acquas E, A Bachis, RL Nosheny, I Cernak and I Mocchetti (2004) Human immunodeficiency virus type 1 protein gp120 causes neuronal cell death in the rat brain by activating caspases. Neurotoxicity Res. 5, 605-615.
2. Altar CA, CB Boylan, C Jackson, S Hershenson, J Miller, SJ Wiegand, RM Lindsay and C Hyman (1992) Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl. Acad. Sci. USA 89, 11347-11351.
3. Bachis A and I Mocchetti (2004) The chemokine receptor CXCR4 and not the N-methyl-D-aspartate receptor mediates gp120 neurotoxicity in cerebellar granule cells. J. Neurosci. Res. 75, 75-82.
4. Bachis A, EO Major and I Mocchetti (2003) Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization. J. Neurosci. 23, 5715-5722.
5. Bagetta G, MT Corasaniti, L Berliocchi, M Navarra, A Finazzi-Agro and G Nistico (1995) HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat. Biochem. Biophys. Res. Commun. 211, 130-136.
6. Bansal AK, CF Mactutus, A Nath, W Maragos, KF Hauser and RM Booze (2000) Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res. 879, 42-49.
7. Barker PA (2004) p75NTR is positively promiscuous, novel partners and new insights. Neuron 42, 529-533.
8. Bezzi P, M Domercq, L Brambilla, R Galli, D Schols, E De Clercq, A Vescovi, G Bagetta, G Kollias, J Meldolesi and A Volterra (2001) CXCR4-activated astrocyte glutamate release via TNFalpha, amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4, 702-710.
9. Biard-Piechaczyk M, V Robert-Hebmann, V Richard, J Roland, RA Hipskind and C Devaux (2000) Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120). Virology 268, 329-344.
10. Bonni A, A Brunet, AE West, SR Datta, MA Takasu and ME Greenberg (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent BDNF AND gp120 195 mechanisms. Science 286, 1358-1362.
11. Brandoli C, A Sanna, MA De Bernardi, P Follesa, G Brooker and I Mocchetti (1998) Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells. J. Neurosci. 18, 7953-7961.
12. Brunet A, SR Datta and ME Greenberg (2001) Transcription-dependent and -independent control of neuronal survival by the PI3KAkt signaling pathway. Curr. Opin. Neurobiol. 11, 297-305.
13. Cabelli RJ, A Hohn and CJ Shatz (1995) Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF. Science 267, 1662-1666.
14. Carter BD, C Kaltschmidt, B Kaltschmidt, N Offenhauser, R Bohm-Matthaei, PA Baeuerle and YA Barde (1996) Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272, 542-545.
15. Casaccia-Bonnefil P, BD Carter, RT Dobrowsky and MV Chao (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716-719.
16. Chao MV (2003) Neurotrophins and their receptors: A convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299-309.
17. Connor B, D Young, Q Yan, RL Faull, B Synek and M Dragunow (1997) Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res. Mol. Brain Res. 49, 71-81.
18. Corasaniti MT, G Bagetta, D Rotiroti and G Nistico (1998) The HIV envelope protein gp120 in the nervous system, interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling, with pathological implications in vivo and in vitro. Biochem. Pharmacol. 56, 153-156.
19. Courtney MJ, KEO Akerman and ET Coffey (1997) Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two component mechanism. J. Neurosci. 17, 4201-4211.
20. Davis CB, I Dikic, D Unutmaz, CM Hill, J Arthos, MA Siani, DA Thompson, J Schlessinger and DR Littman (1997) Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 186, 1793-1798.
21. Dobrowsky R, M Werner, A Castellino, M Chao and Y Hannun (1994) Activation of the sphingomyelin cycle through the low affinity neurotrophin receptor. Science 265, 1596-1599.
22. Donzella GA, D Schols, SW Lin, JA Este, KA Nagashima, PJ Maddon, GP Allaway, TP Sakmar, G Henson, E De Clercq and JP Moore (1998) AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat. Med. 4, 72-77.
23. Dreyer EB and SA Lipton (1995) The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur. J. Neurosci. 7, 2502-2507.
24. Durany N and J Thome (2004) Neurotrophic factors and the pathophysiology of schizophrenic psychoses. Eur. Psychiatry 19, 326-337.
25. Everall IP, L Hudson, S al-Sarraj, M Honavar, P Lantos and R Kerwin (1995) Decreased expression of AMPA receptor messenger RNA and protein in AIDS, a model for HIV-associated neurotoxicity. Nat. Med. 1, 1174-1178.
26. Fagiolini M, JM Fritschy, K Low, H Mohler, U Rudolph and TK Hensch (2004) Specific GABAA circuits for visual cortical plasticity. Science 303, 1681-1683.
27. Friden PM, LR Walus, P Watson, SR Doctrow, JW Kozarich, C Backman, H Bergman, B Hoffer, F Bloom AC Granholm (1993) Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259, 373-377.
28. Frim DM, TA Uhler, MP Short, ZD Ezzedine, M Klagsbrun, XO Breakefield and O Isacson (1993) Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. Neuroreport 4, 367-370.
29. Gallo V, MT Ciotti, A Coletti, F Aloisi and G Levi (1982) Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc. Natl. Acad. Sci. USA 79, 7919-7923.
30. Garden GA, SL Budd, E Tsai, L Hanson, M Kaul, DM D'Emilia, RM Friedlander, J Yuan, E Masliah and SA Lipton (2002) Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J. Neurosci. 22, 4015-4024.
31. Ghorpade A, S Holter, K Borgmann, R Persidsky and L Wu (2003) HIV-1 and IL-1 beta regulate Fas ligand expression in human astrocytes through the NF-kappa B pathway. J. Neuroimmunol. 141, 141-149.
32. Granholm AC, D Albeck, C Backman, M Curtis, T Ebendal, P Friden, M Henry, B Hoffer, J Kordower, GM Rose, S Soderstrom and RT Bartus (1998) A non-invasive system for delivering neural growth factors across the blood-brain barrier: A review. Rev. Neurosci. 9, 31-55.
33. Gray F, H Adle-Biassette, F Chretien, G Lorin de la Grandmaison, G Force and C Keohane (2001) Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin. Neuropathol. 20, 146-155.
34. Gustafsson E, G Andsberg, V Darsalia, P Mohapel, RJ Mandel, D Kirik, O Lindvall and Z Kokaia (2003) Anterograde delivery of brain-derived neurotrophic factor to striatum via nigral transduction of recombinant adeno-associated virus increases neuronal death but promotes neurogenic response following stroke. Eur. J. Neurosci. 17, 2667-2678.
35. Han BH, A D'Costa, SA Back, M Parsadanian, S Patel, AR Shah, JM Gidday, A Srinivasan, M Deshmukh and DM Holtzman (2000) BDNF blocks caspase-3 activation in neonatal hypoxiaischemia. Neurobiol. Dis. 7, 38-53.
36. Haughey NJ, RG Cutler, A Tamara, JC McArthur, DL Vargas, CA Pardo, J Turchan, A Nath and MP Mattson (2004) Perturbation of sphingolipid metabolism and ceramide production in HIV dementia. Ann. Neurol. 55, 257-267.
37. He J, Y Chen, M Farzan, H Choe, A Ohagen, S Gartner, J Busciglio, X Yang, W Hofmann, W Newman, CR Mackay, J Sodroski and D Gabuzda (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385, 645-649.
38. Hempstead BL (2002) The many faces of p75NTR. Curr. Opin. Neurobiol. 12, 260-267.
39. Hesselgesser J, D Taub, P Baskar, M Greenberg, J Hoxie, DL Kolson and R Horuk (1998) Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr. Biol. 8, 595-598.
40. Higgins GA, S Koh, KS Chen and FH Gage (1989) NGF induction of NGF receptor gene expression and cholinergic neuronal hypertrophy within the basal forebrain of the adult rat. Neuron 3, 247-256.
41. Hoffman TL, G Canziani, L Jia, J Rucker and RW Doms (2000) A biosensor assay for studying ligand-membrane receptor interactions, binding of antibodies and HIV-1 Env to chemokine receptors. Proc. Natl. Acad. Sci. USA 97, 11215-11220.
42. Holtzman DM, Y Li, LF Parada, S Kinsman, CK Chen, JS Valletta, J Zhou, JB Long and WC Mobley (1992) p140trk mRNA marks NGF-responsive forebrain neurons, evidence that trk gene expression is induced by NGF. Neuron 9, 465-478.
43. Huang EJ and LF Reichardt (2003) Trk Receptors, Roles in neuronal signal transduction. Ann. Rev. Biochem. 72, 609-642.
44. Huang ZJ, A Kirkwood, T Pizzorusso, V Porciatti, B Morales, MF Bear, L Maffei and S Tonegawa (1999) BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98, 739-755.
45. Huberman AD and AK McAllister (2002) Neurotrophins and visual cortical plasticity. Prog. Brain Res. 138, 39-51.
46. Hyman C, M Hofer, YA Barde, M Juhasz, GD Yancopoulos, SP Squinto and RM Lindsay (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232.
47. Itoh K, P Mehraein and S Weis (2000) Neuronal damage of the substantia nigra in HIV-1 infected brains. Acta Neuropathol. 99, 376.
48. James HJ, LR Sharer, Q Zhang, HG Wang, LG Epstein, JC Reed and HA Gelbard (1999) Expression of caspase-3 in brains from paediatric patients with HIV-1 encephalitis. Neuropathol. Appl. Neurobiol. 25, 380-386.
49. Jones KR, I Farinas, C Backus and LF Reichardt (1994) Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76, 989-999.
50. Kang HJ and EM Schuman (1995) Neurotrophin-induced modulation of synaptic transmission in the adult hippocampus. J. Physiol. Paris 89, 11-22.
51. Kaul M and SA Lipton (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96, 8212-8216.
52. Kaul M, GA Garden and SA Lipton (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988-994.
53. Klein RL, MH Lewis, N Muzyczka and EM Meyer (1999a) Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer. Brain Res. 847, 314-320.
54. Klein RL, D Muir, MA King, AL Peel, S Zolotukhin, JC Moller, A Kruttgen, JV Heymach Jr, N Muzyczka and EM Meyer (1999b) Long-term actions of vector-derived nerve growth factor or brainderived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain. Neuroscience 90, 815-821.
55. Klein RS, KC Williams, X Alvarez-Hernandez, S Westmoreland, T Force, AA Lackner and AD Luster (1999c) Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J. Immunol. 163, 1636-1646.
56. Koliatsos VE and I Mocchetti (1999) Trophic factors as therapeutic agents for diseases characterized by neuronal death, In: Cell Death and Diseases of the Nervous System (Koliatsos VE and RR Ratan, Eds.) (Humana Press: Totowa, NJ), pp 545-591.
57. Korte M, O Griesbeck, C Gravel, P Carroll, V Staiger, H Thoenen and T Bonhoeffer (1996) Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brainderived neurotrophic factor mutant mice. Proc. Natl. Acad. Sci. USA 93, 12547-12552.
58. Larsson M, L Hagberg, A Forsman and G Norkrans (1991) Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. J. Neurosci. Res. 28, 406-409.
59. Levine ES, RA Crozier, IB Black and MR Plummer (1998) Brainderived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity. Proc. Natl. Acad. Sci. USA 95, 10235-10239.
60. Lipton SA (1992) Models of neuronal injury in AIDS, another role for the NMDA receptor? Trends Neurosci. 15, 75-79.
61. Liu Y, BT Himes, M Murray, A Tessler and I Fischer (2002) Grafts of BDNF-producing fibroblasts rescue axotomized rubrospinal neurons and prevent their atrophy. Exp. Neurol. 178, 150-164.
62. Lyons WE, LA Mamounas, GA Ricaurte, V Coppola, SW Reid, SH Bora, C Wihler, VE Koliatsos and L Tessarollo (1999) Brainderived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl. Acad. Sci. USA 96, 15239-15244.
63. Mamounas LA, ME Blue, JA Siuciak and CA Altar (1995) Brainderived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15, 7929-7939.
64. Marini AM, SJ Rabin, RH Lipsky and I Mocchetti (1998) Activity dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate. J. Biol. Chem. 273, 29394-29399.
65. Masliah E, N Ge and L Mucke (1996) Pathogenesis of HIV-1 associated neurodegeneration. Crit. Rev. Neurobiol. 10, 57-67.
66. Masliah E, RM DeTeresa, ME Mallory and LA Hansen (2000) Changes in pathological findings at autopsy in AIDS cases for the last 15 years. Aids 14, 69-74.
67. Meucci O and RJ Miller (1996) gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures, protective action of TGF-beta1. J. Neurosci. 16, 4080-4088.
68. Meucci O, A Fatatis, AA Simen, TJ Bushell, PW Gray and RJ Miller (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95, 14500-14505.
69. Miller FD and DR Kaplan (2003) Signaling mechanisms underlying dendrite formation. Curr. Opin. Neurobiol. 13, 391-398.
70. Minichiello L, AM Calella, DL Medina, T Bonhoeffer, R Klein and M Korte (2002) Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron 36, 121-137.
71. Misse D, M Cerutti, N Noraz, P Jourdan, J Favero, G Devauchelle, H Yssel, N Taylor and F Veas (1999) A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis. Blood 93, 2454-2462.
72. Mocchetti I and A Bachis (2004) Brain-derived neurotrophic factor activation of TrkB protects neurons from HIV-1/gp120-induced cell death. Crit. Rev. Neurobiol. 16, 51-57.
73. Mocchetti I and JR Wrathall (1995) Neurotrophic factors in central nervous system trauma. J. Neurotrauma 12, 853-870.
74. Murray KD, CM Gall, EG Jones and PJ Isackson (1994) Differential regulation of brain-derived neurotrophic factor and type II calcium/ calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease. Neuroscience 60, 37-48.
75. Nagatsu T, M Mogi, H Ichinose and A Togari (2000) Changes in cytokines and neurotrophins in Parkinson's disease. J. Neural Transm. Suppl.(60), 277-290. Review.
76. Nosheny RL, A Bachis, E Acquas and I Mocchetti (2004) Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo, potential implication for neuronal cell death. Eur. J. Neurosci. 20, 2857-2864.
77. Pardridge WM (2002) Blood-brain barrier drug targeting enables neuroprotection in brain ischemia following delayed intravenous administration of neurotrophins. Adv. Exp. Med. Biol. 513, 397-430.
78. Patterson SL, T Abel, TA Deuel, KC Martin, JC Rose and ER Kandel (1996) Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16, 1137-1145.
79. Perez-Navarro E, AM Canudas, P Akerund, J Alberch and E Arenas (2000) Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons BDNF AND gp120 197 in a rodent model of Huntington's disease. J. Neurochem. 75, 2190-2199.
80. Phillips HS, JM Hains, M Armanini, GR Laramee, SA Johnson and JW Winslow (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7, 695-702.
81. Power C, PA Kong, TO Crawford, S Wesselingh, JD Glass, JC McArthur and BD Trapp (1993) Cerebral white matter changes in acquired immunodeficiency syndrome dementia, alterations of the blood-brain barrier. Ann. Neurol. 34, 339-350.
82. Ramirez SH, JF Sanchez, CA Dimitri, HA Gelbard, S Dewhurst and SB Maggirwar (2001) Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-kappaB (NF-kappaB)-dependent mechanism. J. Neurochem. 78, 874-889.
83. Reichardt LF (2001) Neurotrophic factors: A window into the nervous system, In Neurobiology of the Neurotrophins (FP Graham Publ. Co.: Johnson City, TN), pp 1-28.
84. Reynolds GP and AM Sardar (1996) 5-Hyroxytryptamine deficits in the caudate nucleus in AIDS. AIDS 10, 1303-1304.
85. Rossi D and A Zlotnik (2000) The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242.
86. Sala R, A Viegi, FM Rossi, T Pizzorusso, G Bonanno, M Raiteri and L Maffei (1998) Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex. Eur. J. Neurosci. 10, 2185-2191.
87. Samson M, F Libert, BJ Doranz, J Rucker, C Liesnard, CM Farber, S Saragosti, C Lapoumeroulie, J Cognaux, C Forceille, G Muyldermans, C Verhofstede, G Burtonboy, M Georges, T Imai, S Rana, Y Yi, RJ Smyth, RG Collman, RW Doms, G Vassart and M Parmentier (1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725.
88. Sanders VJ, IP Everall, RW Johnson and E Masliah (2000) Fibroblast growth factor modulates HIV coreceptor CXCR4 expression by neural cells. HNRC Group. J. Neurosci. Res. 59, 671-679.
89. Sardar AM, C Czudek and GP Reynolds (1996) Dopamine deficits in the brain, the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport 7, 910-912.
90. Sattler R and M Tymianski (2001) Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24, 107-129.
91. Shimizu E, K Hashimoto, N Okamura, K Koike, N Komatsu, C Kumakiri, M Nakazato, H Watanabe, N Shinoda, S Okada and M Iyo (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 54, 70-75.
92. Smith DG, GJ Guillemin, L Pemberton, S Kerr, A Nath, GA Smythe and BJ Brew (2001) Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J Neurovirol. 7, 56-60.
93. Song L, A Nath, JD Geiger, A Moore and S Hochman (2003) Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site. J. Neurovirol. 9, 399-403.
94. Tarasova NI, RH Stauber and CJ Michejda (1998) Spontaneous and ligand-induced trafficking of CXC-chemokine receptor 4. J. Biol. Chem. 273, 15883-15886.
95. Thoenen H (1995) Neurotrophins and neuronal plasticity. Science 270, 593-598.
96. Toggas SM and L Mucke (1996) Transgenic models in the study of AIDS dementia complex. Curr. Top. Microbiol. Immunol. 206, 223-241.
97. Tooyama I, T Kawamata, D Walker, T Yamada, K Hanai, H Kimura, M Iwane, K Igarashi, EG McGeer and PL McGeer (1993) Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease. Neurology 43, 372-376.
98. van de Bovenkamp M, HSLM Nottet and CF Pereira (2002) Interactions of human immunodeficiency virus-1 proteins with neurons: Possible role in the development of human immunodeficiency virus-1-associated dementia. Eur. J. Clin. Invest. 32, 619-627.
99. Wang G-J, L Chang, ND Volkow, F Telang, J Logan, T Ernst and JS Fowler (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127, 2452-2458.
100. Weissman D, RL Rabin, J Arthos, A Rubbert, M Dybul, R Swofford, S Venkatesan, JM Farber and AS Fauci (1997) Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389, 981-985.
101. Yamashita T and M Tohyama (2003) The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat. Neurosci. 6, 461-467.
102. Yan Q, MJ Radeke, CR Matheson, J Talvenheimo, AA Welcher and SC Feinstein (1997) Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J. Comp. Neurol. 378, 135-157.
103. Yuan J and BA Yankner (2000) Apoptosis in the nervous system. Nature 407, 802-809.
104. Zakharenko SS, SL Patterson, I Dragatsis, SO Zeitlin, SA Siegelbaum, ER Kandel and A Morozov (2003) Presynaptic BDNF required for a presynaptic but not postsynaptic component of LTP at hippocampal CA1-CA3 synapses. Neuron 39, 975-990.
105. Zheng J, MR Thylin, A Ghorpade, H Xiong, Y Persidsky, R Cotter, D Niemann, M Che, YC Zeng, HA Gelbard, RB Shepard, JM Swartz and HE Gendelman (1999) Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 98, 185-200.